Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil and CBST for Erectile Dysfunction
NCT02450188Phase 4Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Mar 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of vardenafil in erectile dysfunction (ED), sponsored by Università degli Studi di Firenze. Primary endpoint: Erectile Function domain of the International Index of Erectile Function at 10 weeks. Started Mar 2012; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02450188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02450188.